{
    "ticker": "FOXO",
    "name": "FOXO Technologies, Inc.",
    "description": "FOXO Technologies, Inc. is a biotechnology company focused on advancing the field of epigenetics and developing innovative solutions to improve health and longevity. Founded with the mission to transform the way health is monitored and managed, FOXO leverages proprietary technology to analyze epigenetic data, providing insights that can lead to personalized health interventions. The company's flagship product is a suite of health and wellness solutions that utilize epigenetic markers to help individuals understand their biological age and optimize their health trajectories. Through extensive research and collaboration with leading scientists, FOXO is positioned at the forefront of the epigenetic revolution, aiming to empower individuals with actionable information that promotes healthier lifestyles. In addition to consumer-focused health products, FOXO is exploring applications in various sectors including insurance and wellness programs, enabling organizations to enhance their offerings and outcomes through data-driven insights. Committed to innovation and scientific excellence, FOXO Technologies is dedicated to creating a healthier future by harnessing the power of genetic and epigenetic information.",
    "industry": [
        "Biotechnology",
        "Health Technology"
    ],
    "headquarters": "Minneapolis, Minnesota, USA",
    "founded": "2020",
    "website": "https://www.foxotechnologies.com",
    "ceo": "Mark J. Killion",
    "social_media": {
        "twitter": "https://twitter.com/FOXO_Tech",
        "linkedin": "https://www.linkedin.com/company/foxotechnologies/"
    },
    "investor_relations": "https://ir.foxotechnologies.com",
    "key_executives": [
        {
            "name": "Mark J. Killion",
            "position": "CEO"
        },
        {
            "name": "Dr. James K. McRae",
            "position": "Chief Scientific Officer"
        }
    ],
    "product_categories": [
        {
            "category": "Health Solutions",
            "products": [
                "FOXO Health Assessment",
                "FOXO Wellness Program"
            ]
        }
    ],
    "seo": {
        "meta_title": "FOXO Technologies, Inc. | Innovating Health Through Epigenetics",
        "meta_description": "Explore FOXO Technologies, Inc., a leader in biotechnology focused on epigenetic health solutions. Discover innovative products that promote health and longevity.",
        "keywords": [
            "FOXO",
            "Epigenetics",
            "Health Technology",
            "Biotechnology",
            "Health Solutions",
            "Longevity"
        ]
    },
    "faq": [
        {
            "question": "What does FOXO Technologies do?",
            "answer": "FOXO Technologies focuses on epigenetics to provide health assessment and wellness solutions that help individuals optimize their health."
        },
        {
            "question": "Who is the CEO of FOXO Technologies?",
            "answer": "Mark J. Killion is the CEO of FOXO Technologies, Inc."
        },
        {
            "question": "Where is FOXO Technologies headquartered?",
            "answer": "FOXO Technologies is headquartered in Minneapolis, Minnesota, USA."
        },
        {
            "question": "What are FOXO's main products?",
            "answer": "FOXO's main products include the FOXO Health Assessment and the FOXO Wellness Program."
        },
        {
            "question": "When was FOXO Technologies founded?",
            "answer": "FOXO Technologies was founded in 2020."
        }
    ],
    "competitors": [
        "NVTA",
        "GRAIL",
        "EXAS"
    ],
    "related_stocks": [
        "AAPL",
        "AMZN",
        "GOOGL",
        "MSFT"
    ]
}